IMNM
Immunome Inc.
Next earnings Aug 4, 2026 · consensus $-0.54 EPS, $185K rev
Last earnings -1.3% on 2026-05-12
$19.75
▲ +2.17%$19.75▲ +123.67%
over 1Y
L $8.40EODHDH $26.97
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.2%
1W+6.6%
1M-9.9%
3M-2.7%
YTD-5.1%
1Y+123.7%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 21 analysts
Buy
Conservative balance sheet (liabilities/equity 0.08x); but revenue fell -23.2% YoY.
Immunome Inc. shows $6.94M in FY2025 revenue (-23.2% YoY), a -3060.0% net margin, and -33.5% ROE.
Sources: SEC EDGAR (CIK 0001472012, latest 10-Q filed 2026-05-12) · EODHD · as of 6/25/2026, 5:38:29 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.